# A Study of Duloxetine in Fibromyalgia

> **NCT01552057** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 393 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Duloxetine 60 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01552057
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 393 (ACTUAL)
- **Last updated:** 2015-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01552057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01552057, "A Study of Duloxetine in Fibromyalgia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01552057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*